Acorah Software Products - Accounts Production 19.3.600 false true 31 March 2025 1 April 2024 false 1 April 2025 31 March 2026 31 March 2026 14084646 Dr Gregory James iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14084646 2025-03-31 14084646 2026-03-31 14084646 2025-04-01 2026-03-31 14084646 frs-core:ComputerEquipment 2026-03-31 14084646 frs-core:ComputerEquipment 2025-04-01 2026-03-31 14084646 frs-core:ComputerEquipment 2025-03-31 14084646 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-04-01 2026-03-31 14084646 frs-core:NetGoodwill 2026-03-31 14084646 frs-core:NetGoodwill 2025-04-01 2026-03-31 14084646 frs-core:NetGoodwill 2025-03-31 14084646 frs-core:OtherResidualIntangibleAssets 2026-03-31 14084646 frs-core:OtherResidualIntangibleAssets 2025-04-01 2026-03-31 14084646 frs-core:OtherResidualIntangibleAssets 2025-03-31 14084646 frs-core:PlantMachinery 2026-03-31 14084646 frs-core:PlantMachinery 2025-04-01 2026-03-31 14084646 frs-core:PlantMachinery 2025-03-31 14084646 frs-core:ShareCapital 2026-03-31 14084646 frs-core:RetainedEarningsAccumulatedLosses 2026-03-31 14084646 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14084646 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 14084646 frs-bus:SmallEntities 2025-04-01 2026-03-31 14084646 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 14084646 frs-bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 14084646 frs-bus:Director1 2025-04-01 2026-03-31 14084646 frs-countries:EnglandWales 2025-04-01 2026-03-31 14084646 2024-03-31 14084646 2025-03-31 14084646 2024-04-01 2025-03-31 14084646 frs-core:ShareCapital 2025-03-31 14084646 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31
Registered number: 14084646
Kratos Medical Limited
Unaudited Financial Statements
For The Year Ended 31 March 2026
James Khan
Kratos Medical Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—4

Page 1
Kratos Medical Limited
Balance Sheet
As At 31 March 2026
Balance Sheet
Registered number: 14084646

| 2026 | 2025
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Intangible Assets | 4 |  | 6,700 |  | 11,250
Tangible Assets | 5 |  | 55,182 |  | 28,170
|  |  | 61,882 |  | 39,420
CURRENT ASSETS
Cash at bank and in hand |  | 54,679 |  | 30,715 |
|  | 54,679 |  | 30,715 |
Creditors: Amounts Falling Due Within One Year |  | (46,231 ) |  | (20,186 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 8,448 |  | 10,529
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 70,330 |  | 49,949
NET ASSETS |  |  | 70,330 |  | 49,949
CAPITAL AND RESERVES
Called up share capital | 7 |  | 100 |  | 100
Profit and Loss Account |  |  | 70,230 |  | 49,849
SHAREHOLDERS' FUNDS |  |  | 70,330 |  | 49,949

Page 1
Page 2
Kratos Medical Limited
Balance Sheet (continued)
As At 31 March 2026
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr Gregory James Director
26/06/2026

The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Kratos Medical Limited
Notes to the Financial Statements
For The Year Ended 31 March 2026
Notes to the Financial Statements
1. General Information
Kratos Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14084646 . The registered office is Within King Street Gym, Units 7 & 8, Manchester, M2 4LQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It is amortised to profit and loss account over its estimated economic life of 5 years.
2.4. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are the Company Website. It is amortised to profit and loss account over its estimated economic life of five years.
2.5. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 20% Reducing Balance
Computer Equipment | 20% Reducing Balance

2.6. Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to the profit and loss account as incurred.
2.7. Taxation
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Page 3
Page 4
Kratos Medical Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2026
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
4. Intangible Assets

| Goodwill | Other | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 April 2025 | 12,000 | 10,750 | 22,750
As at 31 March 2026 | 12,000 | 10,750 | 22,750
Amortisation
As at 1 April 2025 | 7,200 | 4,300 | 11,500
Provided during the period | 2,400 | 2,150 | 4,550
As at 31 March 2026 | 9,600 | 6,450 | 16,050
Net Book Value
As at 31 March 2026 | 2,400 | 4,300 | 6,700
As at 1 April 2025 | 4,800 | 6,450 | 11,250

5. Tangible Assets

| Plant & Machinery | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 April 2025 | 39,825 | 1,429 | 41,254
Additions | 42,688 | 1,391 | 44,079
As at 31 March 2026 | 82,513 | 2,820 | 85,333
Depreciation
As at 1 April 2025 | 12,396 | 688 | 13,084
Provided during the period | 16,503 | 564 | 17,067
As at 31 March 2026 | 28,899 | 1,252 | 30,151
Net Book Value
As at 31 March 2026 | 53,614 | 1,568 | 55,182
As at 1 April 2025 | 27,429 | 741 | 28,170

7. Share Capital

| 2026 |  | 2025
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

Page 4